OR WAIT 15 SECS
© 2021 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
Results of a multicenter FDA clinical trial of a fourth-generation version of an accommodating IOL (crystalens HD-100, eyeonics/Bausch & Lomb) demonstrate that the lens provides excellent uncorrected visual acuity at all distances that exceeds those of previous versions and without causing loss of contrast sensitivity.
Related Content:
News